Meet The Professors
Understanding the Current and Future Role of Oral SERDs (Selective Estrogen Receptor Degraders) in the Management of ER-Positive Metastatic Breast Cancer
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:37:38
- More information
Informações:
Synopsis
Dr Komal Jhaveri from Memorial Sloan Kettering Cancer Center in New York City discusses available and emerging data with oral SERDs for patients with ER-positive metastatic breast cancer. CME information and select publications here.
